B cell maturation antigen is a novel target for immunotherapy of acute myeloid leukemia
J Hematol Oncol. 2025 Oct 24;18(1):89. doi: 10.1186/s13045-025-01741-y. ABSTRACT B cell maturation antigen (BCMA) has emerged as a prominent immunotherapeutic target in multiple myeloma (MM) …